canadaopportunities said:
Hi there, This forum is really informative specially this post as we are also facing a difficult situation as well. Our application as a family is under the federal skilled worker category and we are also planning to migrate to Canada but unfortunately I, as a principal sponsor, was diagnosed with HIV and that lead us to a probable medical inadmissibility. Iam under medication now specifically lamivudine zidovudine nevirapine, and in a good health with normal cd4 count. We are also on our last phase because we already received Fairness letter from the embassy giving us 60 days to comply. Hopefully someone can also help us with our case. Please if anyone hear who can help us choose the possible option we appreciate that . Thank you very much
That is the
only drug therapy combination that currently does not exceed the excessive demand threshold, even when 100% paid for by a provincial government. That is because all three of those drugs are generics.
Pricing data for Canada is difficult to find, but I usually use the RAMQ (Quebec's published listing) as it is generally comparable to what other provinces would pay as well.
https://www.prod.ramq.gouv.qc.ca/DPI/PO/Commun/PDF/Liste_Med/Liste_Med/liste_med_2014_03_14_en.pdf
Lamivudine/Zidovudine ("Combivir" is the non-generic name, but it is priced the same as the Teva generic) is $156.12 per month (assuming twice per day dosing)
Nevirapine ("Viramune" is the non-generic name) is $74.08 per month (again, assuming twice per day dosing).
This is a total cost of $2762.40 per month and is
far below the excessive demand threshold (which is currently ~$6300). It is distinctly possible that even with this information the medical officer may still try to classify you as excessive demand, but if you provide the written information about costs, that opinion would not withstand scrutiny.
Thus, at the present time based upon your therapy, you are not excessive demand.